Legis Daily

A bill to clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

USA115th CongressS-2493| Senate 
| Updated: 3/5/2018
Joe Manchin

Joe Manchin

Independent Senator

West Virginia

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
DEA Enforcement and Authority Act of 2018 This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA). The bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, it eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan. Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2018
Introduced in Senate
Mar 5, 2018
Read twice and referred to the Committee on the Judiciary.
Oct 9, 2018

Latest Companion Bill Action

HR 115-6702
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 5, 2018
    Introduced in Senate


  • March 5, 2018
    Read twice and referred to the Committee on the Judiciary.


  • October 9, 2018

    Latest Companion Bill Action

    HR 115-6702
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Crime and Law Enforcement

Related Bills

  • HR 115-6702: To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
Administrative remediesDepartment of JusticeDrug Enforcement Administration (DEA)Drug trafficking and controlled substancesLicensing and registrations

A bill to clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

USA115th CongressS-2493| Senate 
| Updated: 3/5/2018
DEA Enforcement and Authority Act of 2018 This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA). The bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, it eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan. Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Mar 5, 2018
Introduced in Senate
Mar 5, 2018
Read twice and referred to the Committee on the Judiciary.
Oct 9, 2018

Latest Companion Bill Action

HR 115-6702
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
  • March 5, 2018
    Introduced in Senate


  • March 5, 2018
    Read twice and referred to the Committee on the Judiciary.


  • October 9, 2018

    Latest Companion Bill Action

    HR 115-6702
    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Joe Manchin

Joe Manchin

Independent Senator

West Virginia

Judiciary Committee

Crime and Law Enforcement

Related Bills

  • HR 115-6702: To clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesDepartment of JusticeDrug Enforcement Administration (DEA)Drug trafficking and controlled substancesLicensing and registrations